Patents-Review.com
🔗 Permalink
Assignee profile:

XSPRAY PHARMA AB

City:

Solna

Country:

Sweden

Published Applications:

22

Last publication date:

2025-12-11

Patent Grants:

18

Last grant date:

2025-09-23

Top Inventors for applications by XSPRAY PHARMA AB

These are the the leading inventors for applications assigned to XSPRAY PHARMA AB:

Recent patent applications by XSPRAY PHARMA AB

XSPRAY PHARMA AB based in Solna, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-11
US20250375449A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB

 #2 | 2025-05-08 ✅ Patent 12,419,892 granted on 2025-09-23
US20250144096A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB

 #3 | 2025-03-20 ✅ Patent 12,576,071 granted on 2026-03-17
US20250090511A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

 #4 | 2024-12-05
US20240398769A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

 #5 | 2024-11-14 ✅ Patent 12,144,804 granted on 2024-11-19
US20240374577A1
Human necessities

Pharmaceutical compositions

 #6 | 2024-06-13 ✅ Patent 12,076,314 granted on 2024-09-03
US20240189290A1
Human necessities

Pharmaceutical compositions

 #7 | 2024-01-25
US20240024248A1
Human necessities

FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS

 #8 | 2023-04-20
US20230121325A1
Human necessities

FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS

 #9 | 2022-09-22 ✅ Patent 11,517,562 granted on 2022-12-06
US20220296575A1
Human necessities

Pharmaceutical compositions

 #10 | 2022-08-18 ✅ Patent 11,833,249 granted on 2023-12-05
US20220257519A1
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #11 | 2022-07-28 ✅ Patent 11,529,351 granted on 2022-12-20
US20220233532A1
Human necessities

Fast dissolving pharmaceutical compositions

 #12 | 2022-06-02 ✅ Patent 11,376,243 granted on 2022-07-05
US20220168285A1
Human necessities

Pharmaceutical compositions

 #13 | 2022-05-26 ✅ Patent 11,426,391 granted on 2022-08-30
US20220160687A1
Human necessities

Pharmaceutical compositions

 #14 | 2022-04-21 ✅ Patent 11,963,951 granted on 2024-04-23
US20220117947A1
Human necessities

Pharmaceutical compositions

 #15 | 2021-04-01 ✅ Patent 11,241,419 granted on 2022-02-08
US20210093616A1
Human necessities

Pharmaceutical compositions

 #16 | 2021-03-25 ✅ Patent 11,344,500 granted on 2022-05-31
US20210085609A1
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #17 | 2021-01-19 ✅ Patent 10,894,018 granted on 2021-01-19
US17004153
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #18 | 2021-01-19 ✅ Patent 10,894,017 granted on 2021-01-19
US17004146
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #19 | 2020-12-29 ✅ Patent 10,874,614 granted on 2020-12-29
US17004107
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #20 | 2020-12-29 ✅ Patent 10,874,613 granted on 2020-12-29
US17004075
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #21 | 2020-12-22 ✅ Patent 10,869,837 granted on 2020-12-22
US17004137
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

 #22 | 2020-12-22 ✅ Patent 10,869,836 granted on 2020-12-22
US17004119
Human necessities

Rapidly disintegrating solid oral dosage forms containing dasatinib

Also check out XSPRAY PHARMA AB's (Solna, Sweden) applicant profile with 21 patent applications submitted.

AssigneeID:

308738 ⎘